John E. Bailey

Insider Reports History

Location
Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John E. Bailey:

Company Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. President and CEO, Director Common Stock 0 $0 $2.51 18 Sep 2024 Direct
G1 Therapeutics, Inc. President and CEO, Director Stock Option (right to buy) 0 18 Sep 2024 Direct

Insider Reports Filed by John E. Bailey

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GTHX G1 Therapeutics, Inc. 18 Sep 2024 5 $0 4 President and CEO, Director 18 Sep 2024, 16:15
GTHX G1 Therapeutics, Inc. 05 Jul 2024 1 -$19,214 4 President and CEO, Director 08 Jul 2024, 17:53
GTHX G1 Therapeutics, Inc. 01 Jul 2024 1 $0 4 President and CEO, Director 03 Jul 2024, 17:22
GTHX G1 Therapeutics, Inc. 13 May 2024 1 -$178,421 4 President and CEO, Director 15 May 2024, 16:06
GTHX G1 Therapeutics, Inc. 03 Jan 2024 4 -$36,447 4 President and CEO, Director 08 Jan 2024, 06:02
GTHX G1 Therapeutics, Inc. 02 Jan 2024 1 -$108,006 4 President and CEO, Director 02 Jan 2024, 19:44
GTHX G1 Therapeutics, Inc. 05 Jul 2023 1 -$6,672 4 President and CEO, Director 07 Jul 2023, 16:07
GTHX G1 Therapeutics, Inc. 10 May 2023 1 $0 4 President and CEO, Director 12 May 2023, 16:16
GTHX G1 Therapeutics, Inc. 03 Jan 2023 4 -$218,714 4 President and CEO, Director 05 Jan 2023, 19:23
GTHX G1 Therapeutics, Inc. 03 Jan 2022 3 -$355,262 4 President and CEO, Director 05 Jan 2022, 19:24